Source: Annual Congress 2007 - Airway regulation, provocation and monitoring - III
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. H. Boskabady (Khorassan, Islamic Republic Of Iran). COPD and airway responsiveness to beta-agonists. Eur Respir J 2007; 30: Suppl. 51, 3622

Member's Comments

No comment yet.

Related content which might interest you: Flow-volume responsiveness to bronchodilators in COPD Source: Eur Respir J 2003; 22: Suppl. 45, 51s Year: 2003 Rapid protective effect of inhaled fluticasone on airway hyperresponsiveness to AMP in patients with fixed airway obstruction due to asthma but not COPD Source: Eur Respir J 2006; 28: Suppl. 50, 670s Year: 2006 Airway inflammation and inhaled corticosteroids in COPD Source: Eur Respir J, 49 (6) 1700289; 10.1183/13993003.00289-2017 Year: 2017 Inhaled corticosteroids and growth of airway function in asthmatic children Source: Eur Respir J 2004; 23: 861-868 Year: 2004 Airway inflammation in COPD after long-term withdrawal of inhaled corticosteroids Source: Eur Respir J, 49 (6) 1700848; 10.1183/13993003.00848-2017 Year: 2017 Airway inflammation in COPD after long-term withdrawal of inhaled corticosteroids Source: Eur Respir J 2017; 49(1): 1600839; DOI: 10.1183/13993003.00839-2016 Year: 2017 Dissociation in effects of fluticasone but not fluticasone/salmeterol on lung function and airway hyperresponsiveness in mild persistent asthma Source: Eur Respir J 2002; 20: Suppl. 38, 385s Year: 2002 Evaluation of the response of airway obstruction to short-acting inhaled broncodilators with using FIV1 and FEV1 in COPD patients Source: Eur Respir J 2005; 26: Suppl. 49, 290s Year: 2005 Differences in responsiveness of airways to AMP and methacholine in asthma and COPD Source: Eur Respir J 2001; 18: Suppl. 33, 93s Year: 2001 Assessing regional airways responses to inhaled bronchodilators in asthmatics Source: Annual Congress 2010 - Airways mechanics in different applications Year: 2010 Acute protective effect of inhaled fluticasone on airway hyperresponsiveness to adenosine 5’-monophosphate in asthma but not in chronic obstructive pulmonary disease Source: Eur Respir J 2004; 24: Suppl. 48, 442s Year: 2004 Bronchial hyperresponsiveness to methacholine/AMP and the bronchodilator response in asthmatic children Source: Eur Respir J 2011; 37: 800-805 Year: 2011 Small airways and hyperresponsiveness in asthma and COPD Source: International Congress 2017 – Sadoul Lecture: "Airway hyperresponsiveness: the riddle of asthma and COPD" and related topics Year: 2017 Assessment of bronchial hyperreactivity, maximal airway response and response to inhaled corticosteriod treatment in patients with bronchiectasis Source: Annual Congress 2007 - Current issues in airway physiology, pharmacology and monitoring Year: 2007 Inhibition of allergen-induced airway remodelling by tiotropium and budesonide: a comparison Source: Eur Respir J 2007; 30: 653-661 Year: 2007 Involvement of airway eosinophilia and airway hyperresponsiveness in management and therapy for COPD> Source: Virtual Congress 2020 – Clinical studies of COPD: combination inhalers and much more Year: 2020 Dose response for inhaled fluticasone on airway and systemic inflammation in COPD Source: Annual Congress 2009 - Drug effects in COPD Year: 2009 Dose–response for inhaled fluticasone on airway and systemic inflammation in COPD Source: Eur Respir J 2011; 37: 206-209 Year: 2011 Dose reduction of inhaled corticosteroids under concomitant medication with montelukast in patients with asthma Source: Eur Respir J 2002; 20: 1080-1087 Year: 2002 Effects of ciclesonide on the management of stable COPD with airway eosinophilia Source: Annual Congress 2013 –COPD treatment and others Year: 2013